Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2018

Open Access 01-12-2018 | Case report

Recurrent hypoglycemia secondary to metformin toxicity in the absence of co-ingestions: a case report

Authors: Sarah Aldobeaban, Bandr Mzahim, Abdussalam Ali Alshehri

Published in: Journal of Medical Case Reports | Issue 1/2018

Login to get access

Abstract

Background

Metformin toxicity is well known to cause lactic acidosis. Multiple cases of hypoglycemia due to isolated metformin overdose have been reported. Increased glucose consumption secondary to anaerobic metabolism has been reported as a possible explanation.

Case presentation

A 23-year-old Arabic woman took 30 g of metformin. In the emergency department, 4 hours after of the event, she was fatigued but vitally stable. During her hospitalization, she had severe lactic acidosis, hypotension corrected with fluid boluses and vasopressors, and multiple episodes of hypoglycemia (6.3 mg/dL, 38 mg/dL, and 42 mg/dL), requiring multiple 50% dextrose-water boluses. The three hypoglycemic episodes occurred coincident with severe lactic acidosis. She improved after 24 hours of continuous renal replacement therapy.

Conclusions

Hypoglycemia can be induced by metformin toxicity in the absence of co-ingestants. A possible explanation of metformin-induced hypoglycemia is increased glucose consumption due to anaerobic metabolism, decreased oral intake, decreased liver glucose production, and decreased glucose absorption.
Literature
1.
go back to reference Viollet B, Guigas B, Sanz Garcia N, Leclerc J, Foretz M, Andreelli F. Cellular and molecular mechanisms of metformin: an overview. Clin Sci (Lond). 2012;122:253–70.CrossRef Viollet B, Guigas B, Sanz Garcia N, Leclerc J, Foretz M, Andreelli F. Cellular and molecular mechanisms of metformin: an overview. Clin Sci (Lond). 2012;122:253–70.CrossRef
2.
go back to reference Bell PM, Hadden DR. Metformin. Endocrinol Metab Clin N Am. 1997;26:523–37.CrossRef Bell PM, Hadden DR. Metformin. Endocrinol Metab Clin N Am. 1997;26:523–37.CrossRef
3.
go back to reference Madiraju AK, Erion DM, Rahimi Y, et al. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature. 2014;510:542–6.CrossRefPubMedPubMedCentral Madiraju AK, Erion DM, Rahimi Y, et al. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature. 2014;510:542–6.CrossRefPubMedPubMedCentral
4.
go back to reference Perrone J, Phillips C, Gaieski D. Occult metformin toxicity in three patients with profound lactic acidosis. J Emerg Med. 2011;40:271–5.CrossRefPubMed Perrone J, Phillips C, Gaieski D. Occult metformin toxicity in three patients with profound lactic acidosis. J Emerg Med. 2011;40:271–5.CrossRefPubMed
5.
go back to reference Salpeter SR, Greyber E, Pasternak GA, Salpeter EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev. 2010;(4):CD002967. Salpeter SR, Greyber E, Pasternak GA, Salpeter EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev. 2010;(4):CD002967.
6.
go back to reference Von Mach MA, Sauer O, Sacha Weilemann L. Experiences of a poison center with metformin – associated lactic acidosis. Exp Clin Endocrinol Diabetes. 2004;112:187–90.CrossRefPubMed Von Mach MA, Sauer O, Sacha Weilemann L. Experiences of a poison center with metformin – associated lactic acidosis. Exp Clin Endocrinol Diabetes. 2004;112:187–90.CrossRefPubMed
7.
go back to reference Galea M, Jelacin N, Bramham K, White I. Severe lactic acidosis and rhabdomyolysis following metfromin and ramipril overdose. Br J Anaesth. 2007;98:213–5.CrossRefPubMed Galea M, Jelacin N, Bramham K, White I. Severe lactic acidosis and rhabdomyolysis following metfromin and ramipril overdose. Br J Anaesth. 2007;98:213–5.CrossRefPubMed
8.
go back to reference Lacher M, Hermanns-Clausen M, Haeffiner K, Bradis M, Pohl M. Severe metformin intoxication with lactic acidosis in an adolescent. Eur J Pediatr. 2005;164:362–5.CrossRefPubMed Lacher M, Hermanns-Clausen M, Haeffiner K, Bradis M, Pohl M. Severe metformin intoxication with lactic acidosis in an adolescent. Eur J Pediatr. 2005;164:362–5.CrossRefPubMed
9.
go back to reference Bodmer M, Meier C, Krähenbühl JSS, Meier CR. Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis. Diabetes Care. 2008;31:2086–91.CrossRefPubMedPubMedCentral Bodmer M, Meier C, Krähenbühl JSS, Meier CR. Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis. Diabetes Care. 2008;31:2086–91.CrossRefPubMedPubMedCentral
10.
go back to reference Ashwell CM, McMurtry JP. Hypoglycemia and reduced feed intake in broiler chickens treated with metformin. Poult Sci. 2003;82:106–10.CrossRefPubMed Ashwell CM, McMurtry JP. Hypoglycemia and reduced feed intake in broiler chickens treated with metformin. Poult Sci. 2003;82:106–10.CrossRefPubMed
11.
go back to reference Spiller HA, Quadrani DA. Toxic effects from metformin exposure. Ann Pharmacother. 2004;38:776–80.CrossRefPubMed Spiller HA, Quadrani DA. Toxic effects from metformin exposure. Ann Pharmacother. 2004;38:776–80.CrossRefPubMed
12.
go back to reference Yang PW, Lin KH, Lo SH, Wang LM, Lin HD. Successful treatment of severe lactic acidosis caused by a suicide attempt with a metformin overdose. Kaohsiung J Med Sci. 2009;25:93–7.CrossRefPubMed Yang PW, Lin KH, Lo SH, Wang LM, Lin HD. Successful treatment of severe lactic acidosis caused by a suicide attempt with a metformin overdose. Kaohsiung J Med Sci. 2009;25:93–7.CrossRefPubMed
13.
go back to reference Rathnapala A, Matthias T, Jayasinghe S. Severe lactic acidosis and acute renal failure following ingestion of metformin and kerosene oil: a case report. J Med Case Rep. 2012;6:18.CrossRefPubMedPubMedCentral Rathnapala A, Matthias T, Jayasinghe S. Severe lactic acidosis and acute renal failure following ingestion of metformin and kerosene oil: a case report. J Med Case Rep. 2012;6:18.CrossRefPubMedPubMedCentral
14.
go back to reference Al-Abri SA, Hayashi S, Thoren KL, Olson KR. Metformin overdose induced hypoglycemia in the absence of other antidiabetic drugs. Clin Toxicol (Phila). 2013;51(5):444–7.CrossRef Al-Abri SA, Hayashi S, Thoren KL, Olson KR. Metformin overdose induced hypoglycemia in the absence of other antidiabetic drugs. Clin Toxicol (Phila). 2013;51(5):444–7.CrossRef
15.
go back to reference Mowry JB, Spyker DA, Brooks DE, McMillan N, Schauben JL. 2014 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 32nd Annual Report. Clinical Toxicol (Phila). 2015;53(10):962–1147.CrossRef Mowry JB, Spyker DA, Brooks DE, McMillan N, Schauben JL. 2014 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 32nd Annual Report. Clinical Toxicol (Phila). 2015;53(10):962–1147.CrossRef
16.
go back to reference Forrester MB. Adult metformin ingestions reported to Texas poison control centers, 2000 – 2006. Hum Exp Toxicol. 2008;27:575–83.CrossRefPubMed Forrester MB. Adult metformin ingestions reported to Texas poison control centers, 2000 – 2006. Hum Exp Toxicol. 2008;27:575–83.CrossRefPubMed
17.
go back to reference Zitzmann S, ReimannI R, Schmechel H. Severe hypoglycemia in an elderly patient treated with metformin. Int J Clin Pharmacol Ther. 2002;40:108–10.CrossRefPubMed Zitzmann S, ReimannI R, Schmechel H. Severe hypoglycemia in an elderly patient treated with metformin. Int J Clin Pharmacol Ther. 2002;40:108–10.CrossRefPubMed
18.
go back to reference Omari A, Yue DK, Twigg SM. Exercise, metformin and hypoglycemia, a neglected entity. Br J Diabetes Vasc Dis. 2005;5:106.CrossRef Omari A, Yue DK, Twigg SM. Exercise, metformin and hypoglycemia, a neglected entity. Br J Diabetes Vasc Dis. 2005;5:106.CrossRef
20.
go back to reference Gjedde S, Christiansen A, Pedersen SB, Rungby J. Survival following a metformin overdose of 63 g: a case report. Pharmacol Toxicol. 2003;93:98–9.CrossRefPubMed Gjedde S, Christiansen A, Pedersen SB, Rungby J. Survival following a metformin overdose of 63 g: a case report. Pharmacol Toxicol. 2003;93:98–9.CrossRefPubMed
21.
go back to reference Protti A. One other explanation for hypoglycemia during metformin overdose. Clin Toxicol (Phila). 2013;51(6):515.CrossRef Protti A. One other explanation for hypoglycemia during metformin overdose. Clin Toxicol (Phila). 2013;51(6):515.CrossRef
22.
go back to reference Graham GG, Punt J, Arora M, Day RO, Doogue MP, Duong JK, et al. Clinical pharmacokinetics of metformin. Clin Pharmacokinet. 2011;50:81–98.CrossRefPubMed Graham GG, Punt J, Arora M, Day RO, Doogue MP, Duong JK, et al. Clinical pharmacokinetics of metformin. Clin Pharmacokinet. 2011;50:81–98.CrossRefPubMed
23.
go back to reference Ciarimboli G. Role of organic cation transporters in drug-induced toxicity. Expert Opin Drug Metab Toxicol. 2011;7:159–74.CrossRefPubMed Ciarimboli G. Role of organic cation transporters in drug-induced toxicity. Expert Opin Drug Metab Toxicol. 2011;7:159–74.CrossRefPubMed
24.
go back to reference Shikata E, Yamamoto R, Takanr H, Shigemasa C, Ikeda T, Otsubo K, Ieiri I. Human OrGANIC cation transporter (OCT1 and OCT2) gene polymorphisms and therapeutic effects of metformin. J Hum Genet. 2007;52:117–22.CrossRefPubMed Shikata E, Yamamoto R, Takanr H, Shigemasa C, Ikeda T, Otsubo K, Ieiri I. Human OrGANIC cation transporter (OCT1 and OCT2) gene polymorphisms and therapeutic effects of metformin. J Hum Genet. 2007;52:117–22.CrossRefPubMed
25.
go back to reference Cho SK, Yoon JS, Lee MG, Lee DH, Lim LA, Park K, et al. Rifampin enhances the glucose-lowering effect of metformin and increases OCT1 mRNA levels in healthy participants. Clin Pharmacol Ther. 2011;89:416–21.CrossRefPubMed Cho SK, Yoon JS, Lee MG, Lee DH, Lim LA, Park K, et al. Rifampin enhances the glucose-lowering effect of metformin and increases OCT1 mRNA levels in healthy participants. Clin Pharmacol Ther. 2011;89:416–21.CrossRefPubMed
26.
go back to reference Tzvetkov MV, Vormfelde SV, Balen D, Meinekei I, Schmidt T, Sehrt D. The effects of genetic polymorphisms in the organic cation transporters OCT1, OCT2, and OCT3 on the renal clearance of metformin. Clin Pharmacol Ther. 2009;86:299–306.CrossRefPubMed Tzvetkov MV, Vormfelde SV, Balen D, Meinekei I, Schmidt T, Sehrt D. The effects of genetic polymorphisms in the organic cation transporters OCT1, OCT2, and OCT3 on the renal clearance of metformin. Clin Pharmacol Ther. 2009;86:299–306.CrossRefPubMed
Metadata
Title
Recurrent hypoglycemia secondary to metformin toxicity in the absence of co-ingestions: a case report
Authors
Sarah Aldobeaban
Bandr Mzahim
Abdussalam Ali Alshehri
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2018
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-018-1758-0

Other articles of this Issue 1/2018

Journal of Medical Case Reports 1/2018 Go to the issue